Get the Stockscreener App
2.74
5.99%
-0.18
Sana Biotechnology Inc stock is traded at $2.74, with a volume of 877.13K.
It is down -5.99% in the last 24 hours and down -2.31% over the past month.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others.
See More
Previous Close:
$2.92
Open:
$2.92
24h Volume:
877.13K
Relative Volume:
0.14
Market Cap:
$648.60M
Revenue:
-
Net Income/Loss:
$-283.26M
P/E Ratio:
-1.8639
EPS:
-1.47
Net Cash Flow:
$-273.61M
1W Performance:
+7.65%
1M Performance:
-2.31%
6M Performance:
-38.59%
1Y Performance:
-72.13%
1-Day Range:
$2.74
$2.995
1-Week Range:
$2.49
$2.995
52-Week Range:
$1.52
$10.50
Sana Biotechnology Inc Stock (SANA) Company Profile
Name
Sana Biotechnology Inc
Sector
Industry
Phone
(206) 701-7914
Address
188 EAST BLAINE STREET, SUITE 400, SEATTLE
Compare SANA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
2.741 | 648.60M | 0 | -283.26M | -273.61M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
499.64 | 130.96B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
678.36 | 75.53B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
577.62 | 35.07B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.21 | 31.72B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
249.13 | 26.76B | 3.32B | -860.46M | -1.04B | -8.32 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-25 | Upgrade | TD Cowen | Hold → Buy |
| Nov-05-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jun-26-24 | Initiated | Rodman & Renshaw | Buy |
| Jan-16-24 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Sep-25-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-05-23 | Initiated | Citigroup | Buy |
| Aug-14-23 | Initiated | TD Cowen | Market Perform |
| May-02-23 | Initiated | H.C. Wainwright | Neutral |
| Mar-01-21 | Initiated | BofA Securities | Buy |
| Mar-01-21 | Initiated | Goldman | Neutral |
| Mar-01-21 | Initiated | JP Morgan | Neutral |
| Mar-01-21 | Initiated | Morgan Stanley | Overweight |
View All
Sana Biotechnology Inc Stock (SANA) Latest News
Analyzing Scilex (NASDAQ:SCLX) and Sana Biotechnology (NASDAQ:SANA) - Defense World
SANASana Biotechnology, Inc. Latest Stock News & Market Updates - StockTitan
SANA Gears Up to Report Q4 Earnings: What's in the Cards? - MSN
Sana Biotechnology options imply 6.3% move in share price post-earnings - TipRanks
CAR T-cell Therapy Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain - GlobeNewswire Inc.
Is Sana Biotechnology (SANA) Among Jeff Bezos’ Investments in 2025? - Yahoo Finance
Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025 - Insider Monkey
Why Sana Biotechnology, Inc. (SANA) is Skyrocketing So Far in 2025 - Insider Monkey
Sana Biotechnology (NASDAQ:SANA) Trading 6.3% HigherStill a Buy? - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Trading Down 8.9%What's Next? - MarketBeat
Sana Biotechnology (SANA) to Release Quarterly Earnings on Thursday - Defense World
Sana Biotechnology to Present at the Cowen 45th Annual Health Care Conference - GlobeNewswire
Can Sana's Next-Gen Cell Therapies Disrupt the Biotech Market? CEO Reveals Strategy at Cowen - StockTitan
Flagship Pioneering Appoints Paul Owen as CEO-Partner and CEO of YourBio Health - Quantisnow
Sana Biotechnology (NASDAQ:SANA) Stock Price Up 9.8%Should You Buy? - MarketBeat
Metalpha Technology Holding And 2 Other US Penny Stocks To Monitor - Simply Wall St
Layoff Tracker: Encoded Lays Off 29% of Employees - BioSpace
11 Stocks Jeff Bezos Is Buying | Investing - U.S News & World Report Money
Sana Biotechnology (NASDAQ:SANA) Stock Price Down 7.5%Here's What Happened - MarketBeat
146,491 Shares in Sana Biotechnology, Inc. (NASDAQ:SANA) Purchased by SG Americas Securities LLC - MarketBeat
SG Americas Securities LLC Buys New Position in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Sana Biotechnology (NASDAQ:SANA) Trading Down 6.2%Here's Why - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Trading Up 8.8%What's Next? - MarketBeat
Vanguard Group Inc. Reduces Stake in Sana Biotechnology Inc. - GuruFocus.com
Retail Traders Flocked To These 5 Biotech Stocks In January — Here’s Why - Asianet Newsable
Sana Biotechnology, Inc. (SANA): A Bull Case Theory - MSN
Sana Biotechnology (NASDAQ:SANA) Shares Up 13.9%Time to Buy? - MarketBeat
Sana Biotechnology, Inc. Being Investigated on Behalf of Sana Biotechnology, Inc. Investors. Contact Levi & Korsinsky For Details. - ACCESS Newswire
Shareholder Rights Advocates at Levi & Korsinsky Investigate Sana Biotechnology, Inc. (SANA) Regarding Possible Securities Fraud Violations - ACCESS Newswire
Flagship Pioneering, Cambridge University Health Partners, and Milner Therapeutics Institute Announce Collaboration to Accelerate Biotech Research and Innovation - Quantisnow
Sana Biotech extends rally as Morgan Stanley cites platform's potential - MSN
Vir, Sana gain new modality POC: BioCentury’s Clinical Report - BioCentury
Sana Biotechnology (NASDAQ:SANA) Trading Down 6.5%Here's Why - MarketBeat
Sana Biotechnology (NASDAQ:SANA) Trading 13.9% HigherHere's Why - MarketBeat
Is Sana Biotechnology, Inc. (SANA) the Hottest Smid-Cap Stock So Far In 2025? - MSN
There May Still Be Time to Get in on These 3 Trending Biotechs - MarketBeat
Sana Biotechnology Inc (SANA-Q) QuotePress Release - The Globe and Mail
JPMorgan Chase & Co. Cuts Stock Position in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Sana Biotechnology Inc Stock (SANA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sana Biotechnology Inc Stock (SANA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Cassidy Bernard J | EVP & General Counsel |
Mar 07 '25 |
Option Exercise |
0.00 |
11,041 |
0 |
115,823 |
| Harr Steve | President & CEO |
Mar 07 '25 |
Option Exercise |
0.00 |
50,000 |
0 |
7,889,750 |
| Wyrick Susan D. | See Remarks |
Mar 02 '25 |
Option Exercise |
0.00 |
1,525 |
0 |
155,471 |
5.68%
0.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):